Targeting aggressive cancer
Carrick Therapeutics has raised €86M across 1 funding round from 5 investors, most recently a Series A round in Oct 2016. Based in Dublin, Ireland; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-10-01 | Series A |
| €86M |
| Cambridge Enterprise,Cambridge Innovation Capital,GV (Google Ventures),Lightstone Ventures,Woodford Investment Management |
| View deal → |
